The macrophage: the intersection between HIV infection and atherosclerosis.
about
Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusIncreased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and TatHIV-derived ssRNA binds to TLR8 to induce inflammation-driven macrophage foam cell formationCD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infectionAccelerated atherosclerosis in a human immunodeficiency virus infected patient not on highly active anti-retroviral therapy: An autopsy case report.Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.Functional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage.Macrophages and HIV-1: An Unhealthy Constellation.HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis.Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infectionDifferential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS productionPhosphodiesterase 8a supports HIV-1 replication in macrophages at the level of reverse transcriptionAssociations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapySuccessful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapyHigh dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trialHIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): a prospective cross-sectional studyAtorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone.Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I.Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 ReplicationHIV-1 Nef in macrophage-mediated disease pathogenesis.Immune activation and cardiovascular disease in chronic HIV infection.Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adultsMonocyte/macrophages and their role in HIV neuropathogenesis.Intestinal macrophages and response to microbial encroachment.HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.Analysis of ABCA1 and Cholesterol Efflux in HIV-Infected Cells.A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects.Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases.Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.Cytometry, immunology, and HIV infection: three decades of strong interactions.Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.
P2860
Q26739691-303FDEBF-D092-434A-8268-C84F4EEE0E13Q26851535-B8D20ACA-353C-4BF7-AE32-66FDB5695115Q28080948-69E395F1-BD31-4A2F-A993-6CAF4CA403D4Q28541572-7B30AFE7-F3DE-43D9-9B1A-0E3523122B0AQ28910367-203411CC-5730-4E42-B722-88816DC05833Q30410181-FD5E25FD-5334-4EF2-9754-A776FD78721AQ30593046-BF3D235F-C81D-4CBF-847C-7CE33038EA45Q33721196-3D11C289-F185-497D-BE07-66462AB336E7Q33751356-68F12DDF-967C-429B-827D-680F77BE0E29Q33805298-E42C07AB-456C-43D8-A5BA-5C7698E50247Q33828245-D0B1B899-0BF1-4F54-8C84-787F8264C63AQ33907642-17C50791-16F2-4879-A382-829B7AC890D2Q33916381-E2953D3A-1C0C-43C8-B963-FF5FF2829A1BQ34146122-D11C909E-0B19-4CF5-8D59-81602012C25BQ34292033-E01DE693-0468-460C-A347-61D2FBDEEDDCQ34309051-A44FC73B-E1A7-4C80-A405-D3209F9B3A4EQ34348304-3B7D9CD2-F613-4424-87B1-FBC515E1FBD9Q34761139-6C4AEACF-0B28-4719-8A41-4FEC50BC9B6CQ34763977-DC965427-0C5E-4317-B287-F4D91EBFF2AFQ35068359-620D91A9-A1AE-428A-A157-428A7F2EED1EQ35159845-3D6CF16F-7687-4EFC-93D9-E509F879916EQ35929446-D0A0D011-8B95-4CB7-9F83-88DD6540F060Q36281845-F9D5EA7A-EA61-4736-B3B3-E92DE78EEDBAQ36330954-09AAEDFA-D351-4F43-ACBB-3DEDA399E3D6Q36367791-D1364078-B882-4805-A885-BC499F6357D4Q36466553-F9FC5FC7-07E3-4C44-91D6-DE707E912994Q36531107-B1979F49-8A36-4E80-9DCE-233DDE530D3CQ36556082-4F2CF721-C069-4D02-9612-F5B176ECD9BFQ36634946-6C237499-D3B3-42DD-AB7D-1B80D5BC21E7Q36697990-F1D04961-147E-455E-8721-4B83D6E869DEQ36991666-E50BBCF7-8B80-461E-BF7A-6C98DB8A0013Q37292224-900A9930-E390-4238-8493-45D46F7AAAE2Q37300347-2F9A5574-F8A7-4533-8460-36448772611BQ37304543-9C32DC9A-F085-402C-A2D8-10BBE7EA9444Q37416972-C385BE33-2AC2-4B84-A3B6-41FEA7C49982Q37418053-04AC9B31-89BB-4D0B-8A9A-7373805CBF0EQ37420764-04FCD125-D321-4365-BB94-D9F69AF1FE36Q37862747-50BC4238-8642-42CC-B274-B8F63DEA2804Q38115992-E370C535-48DC-49BF-A8F5-A3B3B4A4931DQ38177684-9EF45B4A-05A8-453A-BBDF-3C891B80B927
P2860
The macrophage: the intersection between HIV infection and atherosclerosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
The macrophage: the intersection between HIV infection and atherosclerosis.
@ast
The macrophage: the intersection between HIV infection and atherosclerosis.
@en
The macrophage: the intersection between HIV infection and atherosclerosis.
@nl
type
label
The macrophage: the intersection between HIV infection and atherosclerosis.
@ast
The macrophage: the intersection between HIV infection and atherosclerosis.
@en
The macrophage: the intersection between HIV infection and atherosclerosis.
@nl
prefLabel
The macrophage: the intersection between HIV infection and atherosclerosis.
@ast
The macrophage: the intersection between HIV infection and atherosclerosis.
@en
The macrophage: the intersection between HIV infection and atherosclerosis.
@nl
P2093
P2860
P921
P356
P1476
The macrophage: the intersection between HIV infection and atherosclerosis
@en
P2093
Anthony Jaworowski
Dmitri Sviridov
Michael Bukrinsky
Nigora Mukhamedova
Suzanne M Crowe
P2860
P304
P356
10.1189/JLB.0809580
P577
2009-12-01T00:00:00Z